Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Nuclear Medicine and Molecular Imaging
Erschienen in: Nuclear Medicine and Molecular Imaging 1/2018

19.05.2017 | Review

Obesity and Brain Positron Emission Tomography

verfasst von: Kyoungjune Pak, Seong-Jang Kim, In Joo Kim

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Obesity, an increasingly common problem in modern societies, results from energy intake chronically exceeding energy expenditure. This imbalance of energy can be triggered by the internal state of the caloric equation (homeostasis) and non-homeostatic factors, such as social, cultural, psychological, environmental factors or food itself. Nowadays, positron emission tomography (PET) radiopharmaceuticals have been examined to understand the cerebral control of food intake in humans. Using 15O–H2 PET, changes in regional cerebral blood flow (rCBF) coupled to neuronal activity were reported in states of fasting, satiation after feeding, and sensory stimulation. In addition, rCBF in obese subjects showed a greater increase in insula, the primary gustatory cortex. 18F–fluorodeoxyglucose PET showed higher metabolic activity in postcentral gyrus of the parietal cortex and lower in prefrontal cortex and anterior cingulate cortex in obese subjects. In addition, dopamine receptor (DR) PET demonstrated lower DR availability in obese subjects, which might lead to overeating to compensate. Brain PET has been utilized to reveal the connectivity between obesity and brain. This could improve understanding of obesity and help develop a new treatment for obesity.
Literatur
1.
2.
3.
4.
Gukovsky I, Li N, Todoric J, Gukovskaya A, Karin M. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1199–209. e4CrossRefPubMedPubMedCentral
5.
Mijovic T, How J, Payne RJ. Obesity and thyroid cancer. Front Biosci (Schol Ed). 2011;3:555–64.
6.
Alzahrani B, Iseli TJ, Hebbard LW. Non-viral causes of liver cancer: does obesity led inflammation play a role? Cancer Lett. 2014;345:223–9.CrossRefPubMed
7.
Gu W, Chen C, Zhao KN. Obesity-associated endometrial and cervical cancers. Front Biosci (Elite Ed). 2013;5:109–18.CrossRef
8.
Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009;1280:186–94.CrossRefPubMedPubMedCentral
9.
Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry. 2007;48:57–61.CrossRefPubMed
10.
11.
Bellisle F, Drewnowski A, Anderson GH, Westerterp-Plantenga M, Martin CK. Sweetness, satiation, and satiety. J Nutr. 2012;142:1149S–54S.CrossRefPubMed
12.
13.
Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20:1–25.CrossRefPubMed
14.
Pecina S, Smith KS, Berridge KC. Hedonic hot spots in the brain. Neuroscientist. 2006;12:500–11.CrossRefPubMed
15.
Naukkarinen J, Surakka I, Pietilainen KH, Rissanen A, Salomaa V, Ripatti S, et al. Use of genome-wide expression data to mine the “gray zone” of GWA studies leads to novel candidate obesity genes. PLoS Genet. 2010;6:e1000976.CrossRefPubMedPubMedCentral
16.
Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24.CrossRefPubMed
17.
Schlogl H, Horstmann A, Villringer A, Stumvoll M. Functional neuroimaging in obesity and the potential for development of novel treatments. Lancet Diabetes Endocrinol. 2016;4:695–705.CrossRefPubMed
18.
Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin. 2015;8:1–31.CrossRefPubMedPubMedCentral
19.
20.
Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12:638–51.CrossRefPubMed
21.
De Araujo IE, Rolls ET. Representation in the human brain of food texture and oral fat. J Neurosci. 2004;24:3086–93.CrossRefPubMed
22.
Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3:655–66.CrossRefPubMed
23.
Yeomans MR. Palatability and the micro-structure of feeding in humans: the appetizer effect. Appetite. 1996;27:119–33.CrossRefPubMed
24.
Cooper SJ. Beta-carbolines characterized as benzodiazepine receptor agonists and inverse agonists produce bi-directional changes in palatable food consumption. Brain Res Bull. 1986;17:627–37.CrossRefPubMed
25.
Levin BE, Routh VH. Role of the brain in energy balance and obesity. Am J Phys. 1996;271:R491–500.
26.
27.
Wise RA. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond Ser B Biol Sci. 2006;361:1149–58.CrossRef
28.
29.
Schultz W. Subjective neuronal coding of reward: temporal value discounting and risk. Eur J Neurosci. 2010;31:2124–35.CrossRefPubMed
30.
Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science. 2008;322:449–52.CrossRefPubMed
31.
Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15:37–46.CrossRefPubMed
32.
Tomasi D, Volkow ND. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol. 2013;48:1–19.CrossRefPubMed
33.
34.
35.
Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res. 2010;1350:18–34.CrossRefPubMedPubMedCentral
36.
Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116:3229–39.CrossRefPubMedPubMedCentral
37.
Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007;12:6–16.CrossRefPubMed
38.
Figlewicz DP, Bennett JL, Aliakbari S, Zavosh A, Sipols AJ. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R388–94.CrossRefPubMedPubMedCentral
39.
Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.CrossRefPubMed
40.
Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev. 2012;13:43–56.CrossRefPubMed
41.
Bennett CM, Miller MB. How reliable are the results from functional magnetic resonance imaging? Ann N Y Acad Sci. 2010;1191:133–55.CrossRefPubMed
42.
Michaelides M, Thanos PK, Volkow ND, Wang GJ. Translational neuroimaging in drug addiction and obesity. ILAR J. 2012;53:59–68.CrossRefPubMed
43.
Raichle ME. Circulatory and metabolic correlates of brain function in normal humans. In Comprehensive physiology. Wiley Online Library. 2011. doi:10.​1002/​cphy.​cp010516
44.
Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA. 1999;96:4569–74.CrossRefPubMedPubMedCentral
45.
Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, et al. Differential brain responses to satiation in obese and lean men. Diabetes. 2000;49:838–46.CrossRefPubMed
46.
DelParigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA. Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast. NeuroImage. 2005;24:436–43.CrossRefPubMed
47.
Kringelbach ML, Rolls ET. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol. 2004;72:341–72.CrossRefPubMed
48.
Le DS, Pannacciulli N, Chen K, Del Parigi A, Salbe AD, Reiman EM, et al. Less activation of the left dorsolateral prefrontal cortex in response to a meal: a feature of obesity. Am J Clin Nutr. 2006;84:725–31.PubMed
49.
DelParigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, et al. Successful dieters have increased neural activity in cortical areas involved in the control of behavior. Int J Obes. 2007;31:440–8.CrossRef
50.
Del Parigi A, Chen K, Gautier JF, Salbe AD, Pratley RE, Ravussin E, et al. Sex differences in the human brain’s response to hunger and satiation. Am J Clin Nutr. 2002;75:1017–22.PubMed
51.
Stephan E, Pardo JV, Faris PL, Hartman BK, Kim SW, Ivanov EH, et al. Functional neuroimaging of gastric distention. J Gastrointest Surg. 2003;7:740–9.CrossRefPubMed
52.
Greenberg JH, Reivich M, Alavi A, Hand P, Rosenquist A, Rintelmann W, et al. Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique. Science. 1981;212:678–80.CrossRefPubMed
53.
Wang GJ, Volkow ND, Telang F, Jayne M, Ma J, Rao M, et al. Exposure to appetitive food stimuli markedly activates the human brain. NeuroImage. 2004;21:1790–7.CrossRefPubMed
54.
Wang GJ, Volkow ND, Felder C, Fowler JS, Levy AV, Pappas NR, et al. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport. 2002;13:1151–5.CrossRefPubMed
55.
Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring). 2009;17:60–5.CrossRef
56.
Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, et al. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci USA. 2009;106:1249–54.CrossRefPubMedPubMedCentral
57.
Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, et al. Brain dopamine and obesity. Lancet. 2001;357:354–7.
58.
Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage. 2003;19:1709–15.CrossRefPubMed
59.
Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10:318–25.CrossRefPubMed
60.
Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage. 2008;42:1537–43.CrossRefPubMedPubMedCentral
61.
Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, et al. “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse. 2002;44:175–80.CrossRefPubMed
62.
Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry. 2014;19:1078–84.CrossRefPubMedPubMedCentral
63.
Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW, Ansari MS, et al. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care. 2012;35:1105–11.CrossRefPubMedPubMedCentral
64.
Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, et al. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse. 2013;67:748–56.CrossRefPubMedPubMedCentral
65.
Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H, et al. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg. 2010;20:369–74.CrossRefPubMed
66.
Dunn JP, Cowan RL, Volkow ND, Feurer ID, Li R, Williams DB, et al. Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res. 2010;1350:123–30.CrossRefPubMedPubMedCentral
67.
Karlsson HK, Tuulari JJ, Tuominen L, Hirvonen J, Honka H, Parkkola R, et al. Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Mol Psychiatry. 2016;21:1057–62.CrossRefPubMed
Metadaten
Titel
Obesity and Brain Positron Emission Tomography
verfasst von
Kyoungjune Pak
Seong-Jang Kim
In Joo Kim
Publikationsdatum
19.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 1/2018
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-017-0483-8

Weitere Artikel der Ausgabe 1/2018

Nuclear Medicine and Molecular Imaging 1/2018 Zur Ausgabe

Case Report

Primary Renal Leiomyosarcoma Presenting with Subcutaneous and Osseous Metastases: Staging and Follow-Up with 18F-FDG PET/CT

Erratum

Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT

Review

Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies

Interesting Image

Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept

Original Article

Prognostic Value of Pre- and Post-Treatment FDG PET/CT Parameters in Small Cell Lung Cancer Patients

Interesting Image

Transiently Altered Distribution of F-18 FDG in a Patient with Subacute Thyroiditis